Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccine development
Pharma
Moderna commits $950M upfront to resolve patent lawsuit
About four years after the case was filed, Moderna has resolved a long-running patent feud with Genevant and Arbutus. Investors celebrated the move.
Fraiser Kansteiner
Mar 4, 2026 10:33am
Bavarian Nordic's longtime CEO Paul Chaplin to depart
Mar 2, 2026 10:23am
Sanofi bolsters adult vaccine roster with $2.2B Dynavax purchase
Dec 29, 2025 10:24am
12 former FDA chiefs blast Prasad's vaccine policy shake-ups
Dec 4, 2025 10:36am
Moderna outlines 3-year business strategy in bid to break even
Nov 20, 2025 2:54pm
GSK adds Moderna's next-gen COVID shot to mRNA patent lawsuit
Sep 5, 2025 10:06am
